# Verification Report

## Summary

- Implemented the requested UI hiding for the production leader `分配报工` dialog: the allocation entry no longer displays the top internal form (`分配说明`, `复核签名ID`, `签名员工ID`, `签名快照`) or the FIFO helper text.
- Kept the formal allocation controls visible: `FIFO 自动分配`, `新增分配行`, the active-order allocation table, and `确认分配`.
- Split submission behavior so allocation-only confirmation no longer depends on hidden signature fields, while review-mode submission still keeps signature validation.

## Commands

- `node tests\e2e\team-leader-report-allocation-dialog-hide-static.spec.cjs` -> PASS.
- `node tests\e2e\team-leader-workbench-static.spec.cjs` -> PASS.
- `node tests\e2e\mes-process-pool-team-leader-static.spec.js` -> PASS.
- `python C:\Users\BJB110\.codex\skills\frontend-feature-delivery\scripts\validate_frontend_feature.py --evidence doc/tasks/20260808-hide-report-assignment-fields/frontend-feature-evidence.md` -> PASS.
- `python C:\Users\BJB110\.codex\skills\backend-api-delivery\scripts\validate_backend_api.py --evidence doc/tasks/20260808-hide-report-assignment-fields/backend-api-evidence.md` -> PASS.
- `git diff --check -- <task-owned paths>` -> PASS; only CRLF normalization warnings appeared.

## Blocked Verification

- `pnpm ts:check` -> BLOCKED by unrelated existing `FrontlineFixedTemplatePanel.vue(1349,7)` type comparison error.
- `mvn -pl yudao-module-mes -am "-Dtest=MesP0TeamLeaderReviewSignatureSchemaTest" "-Dsurefire.failIfNoSpecifiedTests=false" test` -> RED before implementation, then BLOCKED after implementation by unrelated test-compile errors in `MesTeamLeaderFifoAllocationServiceTest` and `MesTeamLeaderWorkbenchServiceImplTest`.
- `mvn -pl yudao-module-mes -am "-DskipTests" compile` -> BLOCKED by same-module Maven concurrency/Javac class-write stall; only the task-owned Maven session was interrupted.

## Final Status

- Task implementation is complete.
- Full completion remains blocked until the unrelated frontend type error and backend test-compile/concurrent Maven baseline are resolved.
